IMCR logo

Immunocore Holdings (IMCR) EBITDA

Annual EBITDA

-$29.89 M
+$21.76 M+42.13%

December 31, 2024


Summary


Performance

IMCR EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIMCRprofitabilitymetrics:

Quarterly EBITDA

-$15.27 M
-$26.18 M-240.04%

December 31, 2024


Summary


Performance

IMCR Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIMCRprofitabilitymetrics:

TTM EBITDA

-$29.57 M
+$8.03 M+21.35%

December 31, 2024


Summary


Performance

IMCR TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIMCRprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

IMCR EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+42.1%0.0%0.0%
3 y3 years+82.1%+64.6%+82.5%
5 y5 years+79.9%+61.1%+80.8%

IMCR EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+82.1%-240.0%+64.6%at high+82.5%
5 y5-yearat high+82.1%-240.0%+66.3%at high+82.5%
alltimeall timeat high+82.1%-240.0%+66.3%at high+82.5%

Immunocore Holdings EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
-$29.89 M(-42.1%)
-$15.27 M(-240.0%)
-$29.57 M(-21.3%)
Sep 2024
-
$10.91 M(-303.0%)
-$37.60 M(-17.1%)
Jun 2024
-
-$5.37 M(-72.9%)
-$45.37 M(-16.8%)
Mar 2024
-
-$19.83 M(-14.9%)
-$54.52 M(+5.6%)
Dec 2023
-$51.65 M(+71.4%)
-$23.30 M(-844.6%)
-$51.65 M(+13.9%)
Sep 2023
-
$3.13 M(-121.5%)
-$45.33 M(+14.6%)
Jun 2023
-
-$14.52 M(-14.4%)
-$39.57 M(+25.3%)
Mar 2023
-
-$16.95 M(-0.2%)
-$31.57 M(-7.2%)
Dec 2022
-$30.14 M
-$16.99 M(-291.1%)
-$34.02 M(-43.5%)
Sep 2022
-
$8.89 M(-236.3%)
-$60.23 M(-44.4%)
Jun 2022
-
-$6.52 M(-66.4%)
-$108.36 M(-26.3%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$19.40 M(-55.1%)
-$147.10 M(-13.0%)
Dec 2021
-$166.72 M(+62.5%)
-$43.20 M(+10.1%)
-$169.00 M(+9.8%)
Sep 2021
-
-$39.24 M(-13.3%)
-$153.95 M(+8.7%)
Jun 2021
-
-$45.26 M(+9.6%)
-$141.60 M(+19.5%)
Mar 2021
-
-$41.31 M(+46.8%)
-$118.52 M(+18.0%)
Dec 2020
-$102.59 M(-30.9%)
-$28.14 M(+4.6%)
-$100.42 M(-12.6%)
Sep 2020
-
-$26.89 M(+21.2%)
-$114.85 M(+30.6%)
Jun 2020
-
-$22.19 M(-4.4%)
-$87.96 M(+33.7%)
Mar 2020
-
-$23.21 M(-45.5%)
-$65.77 M(+54.5%)
Dec 2019
-$148.40 M(+45.0%)
-$42.57 M
-$42.57 M
Dec 2018
-$102.31 M
-
-

FAQ

  • What is Immunocore Holdings annual EBITDA?
  • What is the all time high annual EBITDA for Immunocore Holdings?
  • What is Immunocore Holdings annual EBITDA year-on-year change?
  • What is Immunocore Holdings quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Immunocore Holdings?
  • What is Immunocore Holdings quarterly EBITDA year-on-year change?
  • What is Immunocore Holdings TTM EBITDA?
  • What is the all time high TTM EBITDA for Immunocore Holdings?
  • What is Immunocore Holdings TTM EBITDA year-on-year change?

What is Immunocore Holdings annual EBITDA?

The current annual EBITDA of IMCR is -$29.89 M

What is the all time high annual EBITDA for Immunocore Holdings?

Immunocore Holdings all-time high annual EBITDA is -$29.89 M

What is Immunocore Holdings annual EBITDA year-on-year change?

Over the past year, IMCR annual EBITDA has changed by +$21.76 M (+42.13%)

What is Immunocore Holdings quarterly EBITDA?

The current quarterly EBITDA of IMCR is -$15.27 M

What is the all time high quarterly EBITDA for Immunocore Holdings?

Immunocore Holdings all-time high quarterly EBITDA is $10.91 M

What is Immunocore Holdings quarterly EBITDA year-on-year change?

Over the past year, IMCR quarterly EBITDA has changed by $0.00 (0.00%)

What is Immunocore Holdings TTM EBITDA?

The current TTM EBITDA of IMCR is -$29.57 M

What is the all time high TTM EBITDA for Immunocore Holdings?

Immunocore Holdings all-time high TTM EBITDA is -$29.57 M

What is Immunocore Holdings TTM EBITDA year-on-year change?

Over the past year, IMCR TTM EBITDA has changed by $0.00 (0.00%)